Autoimmune Neuromuscular & Nerve Disorders Drug Development Summit 2026

 

The Autoimmune Neuromuscular & Nerve Disorders Drug Development Summit is the first industry-led forum dedicated to transforming the MG, CIDP, GBS and MMN treatment landscapes, bringing together biopharma leaders to tackle the mechanistic and translational challenges shaping this rapidly evolving space.

This meeting is uniquely positioned to address these challenges. Unlike pathway-specific or clinician-led events, it is indication-focused, mechanism-driven and tailored exclusively to drug developers, enabling deeper discussion on pathophysiology, differentiation and translational strategy.

 

More Info

---

---